Siriraj Genomics Center reveals an extension to breast cancer screening services for everyone. The researchers pointed out Medical technology advances around the world. but important question ‘How can it help people reach out’
Prof. Dr. Manop Pitakphakorn, Head of the Research Center of Excellence in Precision Medicine Siriraj Genomics Center Faculty of Medicine Siriraj Hospital Mahidol University revealed that screening services to find mutations in breast cancer genes. (BRCA1/BRCA2) at the National Health Security Office (NHSO) included in the health promotion and disease prevention benefits (P&P), which all Thai people have every treatment right. Can receive the service without that cost. It is considered useful for Thai women who are at risk of such diseases. and health service system greatly
Because most breast cancer patients are caused by genetic factors. or a direct relative whose family member has had cancer before By causing the risk of cancer as well as up to 50%, but if screened will find out which genes are genetic and will be mutated into cancer genes to stop it first This will help reduce the risk of breast cancer of Thai people.
“In addition, if it is found that there is information from genetic decoding It may make it possible to see the prevention so that risk groups will not have cancer from birth as well, with all 50,000 DNA data of the Genomics Thailand Project. It is very important for future medical treatment. to aim for precision medicine, ” the head of the Research Center of Excellence in Precision Medicine Siriraj Genomics Center said
Prof. Dr. Manop said that such services occurred. It comes from analyzing data obtained from genetic decoding of Thai people who are patients in 5 major disease groups, including cancer, rare diseases, chronic communicable diseases (NCDs), infectious diseases, and pharmacogenetics. Under the Genomics Thailand Integrated Action Plan 2020-2024 (Genomics Thailand), which is regarded as one of the nation’s new medical technologies (Genomics Medicine). As a result, Thailand is the first country in ASEAN that offers genomics services that are accessible to all people. free of charge Although it is the second country to start a Nomix program after Singapore. But it can be seen that the development and extension of medical technology has led to comprehensive health services. Thailand has made great progress.
In addition, even today, medical technology has progressed greatly. especially the development of precision medicine or genomic medicine Especially developed countries that invest seriously in this matter. But the important point is public can access And take advantage of that modern medical technology or not. Because if it is a good, modern medical technology, but its use is limited to certain groups of patients that can be accessed. makes the technology meaningless and has no benefit to the national health system as a whole
“Compared to other countries with similar genomics projects, It is considered that we have an extension that shows great progress. Although the start of genomics Thailand is later than developed countries. But the important thing is when obtaining information from genomic medicine We can extend and push policy. into a package of health service benefits for the whole country,” Prof. Dr. Manop emphasized.
However, now screening for breast cancer in risk groups Even though it is a package of benefits in the National Health Insurance. that covers all populations But access to the service is not yet widespread. Because screening is still limited to large hospitals. in medical school Including cancer center hospital but in the part of community hospitals or small hospitals in some provinces have the potential for screening Or collect items for examination as well, but at this time there is no system or a clear process to support This has resulted in a lack of access to breast cancer screening. to believe that there is a patient and at-risk groups across the country
#benefits #Breast #Cancer #Gene #Testing #Thailand #free #charge #ASEAN
